Clinical trial
Research on Precision Pharmaceutical Care for Heart Transplant Recipients
NCT06326775 is registered in ClinicalTrials.gov with Nanjing First Hospital, Nanjing Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Research on Precision Pharmaceutical Care for Heart Transplant Recipients
- Lead sponsor
- Nanjing First Hospital, Nanjing Medical University
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- March 12, 2024
- Completion date
- December 31, 2026
- Enrollment
- 500 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
heart transplant patients